Vista, CA, United States of America

Claus Andre Frank Rentel

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claus Andre Frank Rentel. Retrieved from https://idiyas.com/inventor/claus-andre-frank-rentel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 112(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Claus Andre Frank Rentel

Introduction

Claus Andre Frank Rentel is an accomplished inventor based in Vista, CA. He has made significant contributions to the field of oligonucleotide synthesis. His work focuses on developing methods for characterizing samples that are essential for creating oligonucleotides.

Latest Patents

Claus holds 1 patent for his invention titled "Compounds and methods for the characterization of oligonucleotides." This patent relates to innovative techniques in oligonucleotide synthesis, providing valuable methods for characterizing samples used in the production of oligonucleotides.

Career Highlights

Claus has been associated with Isis Pharmaceuticals, Inc., where he has applied his expertise in the field of biotechnology. His work has contributed to advancements in genetic research and therapeutic development.

Collaborations

Throughout his career, Claus has collaborated with notable colleagues, including Daniel C. Capaldi and Hans-Joachim Gaus. These partnerships have fostered innovation and enhanced the impact of their collective research efforts.

Conclusion

Claus Andre Frank Rentel's contributions to oligonucleotide synthesis and characterization exemplify the importance of innovation in biotechnology. His work continues to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…